Vigene Biosciences, Inc. — Form D
Vigene Biosciences, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-15. The offering totals $7.5M, of which $7.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-15
- Form: D
- Accession: 0001767643-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $7.5M
- Minimum investment: $1.4M
- Investors: 2
- Date of first sale: 2019-04-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339657
Issuer
- Name: Vigene Biosciences, Inc.
- CIK: 0001767643
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 5 Research Court, ROCKVILLE, MD, 20850
- Phone: 301-251-6638
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Zairen Sun | Executive Officer | Rockville, MD |
Other filings by this issuer (1)
More